Orexin-A is a neuropeptide involved in the regulation of food intake and the sleep-wake cycle. This study investigated plasma orexin-A levels in a sleep clinic cohort, adjusting for smoking habits, in 76 participants comprising 41 with obstructive sleep apnoea (OSA) (apnoea-hypopnoea index [AHI] 44.1 ± 19.1 events/h) and 35 without OSA (AHI 6.3 ± 4.7 events/h). Plasma orexin-A levels were significantly lower in OSA patients (15.0 ± 4.6 ng/ml) compared with those without OSA (31.4 ± 6.5 ng/ml). In non-OSA subjects, there was no significant difference between never smokers and ex/current smokers in plasma orexin-A levels (32.9 ± 9.5 versus 29.7 ± 8.9 ng/ml, respectively) whereas, in the OSA sub-group, orexin-A levels were significantly lower in never smokers than in ex/current smokers (4.0 ± 1.2 versus 21.4 ± 7.0 ng/ml). A significant inverse relationship was found between plasma orexin-A levels and AHI amongst never smokers, but there was no significant relationship amongst ex/current smokers. These results confirm previous studies demonstrating lower levels of plasma orexin-A in OSA patients and indicate that smoking may affect orexin-A levels and AHI.
YoungTPeppardPEGottliebDJ: Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med2002; 165: 1217–1239.
2.
PekerYHednerJNorumJ: Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: A 7-year follow-up. Am J Respir Crit Care Med2002; 166: 159–165.
3.
TaheriSWardHGhateiM: Role of orexins in sleep and arousal mechanisms. Lancet2000; 355: 847.
4.
SutcliffeJGde LeceaL: The hypocretins: Excitatory neuromodulatory peptides for multiple homeostatic systems, including sleep and feeding. J Neurosci Res2000; 62: 161–168.
5.
NishijimaTSakuraiSAriharaZ: Plasma orexin-A-like immunoreactivity in patients with sleep apnea hypopnea syndrome. Peptides2003; 24: 407–411.
6.
SakuraiSNishijimaTTakahashiS: Clinical significance of daytime plasma orexin-A-like immunoreactivity concentrations in patients with obstructive sleep apnea hypopnea syndrome. Respiration2004; 71: 380–384.
7.
BusquetsXBarbeFBarcelo: Decreased plasma levels of orexin-A in sleep apnea. Respiration2004; 71: 575–579.
SakuraiSNishijimaTTakahashiS: Low plasma orexin-A levels were improved by continuous positive airway pressure treatment in patients with severe obstructive sleep apnea-hypopnea syndrome. Chest2005; 127: 731–737.
10.
AdamJAMenheerePPvan DielenFM: Decreased plasma orexin-A levels in obese individuals. Int J Obes Relat Metab Disord2002; 26: 274–276.
SchrandJR: Is sleep apnea a predisposing factor for tobacco use?. Med Hypotheses1996; 47: 443–448.
13.
KashyapRHockLMBowmanTJ: Higher prevalence of smoking in patients diagnosed as having obstructive sleep apnea. Sleep Breath2001; 5: 167–172.
14.
HoffsteinV: Relationship between smoking and sleep apnea in clinic population. Sleep2002; 25: 519–524.
15.
CasasolaGGAlvarez-SalaJLMarquesJA: Smoking behaviour and respiratory alterations during sleep in a healthy population. Sleep Breath2002; 6: 19–24.
16.
JarvikME: Beneficial effects of nicotine. Br J Addict1991; 86: 571–575.
17.
DavilaDGHurtRDOffordKP: Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med1994; 150: 469–474.
18.
LavieLLavieP: Smoking interacts with sleep apnea to increase cardiovascular risk. Sleep Med2008; 9: 247–253.
19.
KaneJKParkerSLMattaSG: Nicotine upregulates expression of orexin and its receptors in rat brain. Endocrinology2000; 141: 3623–3629.
20.
JohnsMW: A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep1991; 14: 540–545.
21.
RechtschaffenAKalesA, (eds): A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subject. Washington DC: US Government Printing Office, National Institute of Health Publication, 1968.
22.
LaviePHererPHoffsteinV: Obstructive sleep apnoea syndrome as a risk factor for hypertension: Population study. BMJ2000; 320: 479–482.
23.
HaganJJLeslieRAPatelS: Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA1999; 96: 10911–10916.
24.
XiMCMoralesFRChaseMH: Effects on sleep and wakefulness of the injection of hypocretin-1 (orexin-A) into the laterodorsal tegmental nucleus of the cat. Brain Res2001; 901: 259–264.
25.
PiperDCUptonNSmithMI: The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci2000; 12: 726–730.
26.
MethipparaMMAlamNSzymusiakR: Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport2000; 11: 3423–3426.
27.
SartinJLDyerCMatteriR: Effect of intracerebroventricular orexin-B on food intake in sheep. J Anim Sci2001; 79: 1573–1577.
28.
SchwartzMW: Orexins and appetite: The big picture of energy homeostasis gets a little bigger. Nat Med1998; 4: 385–386.
29.
KotzCMTeskeJALevineJA: Feeding and activity induced by orexin-A in the lateral hypothalamus in rats. Regul Pept2002; 104: 27–32.
30.
IsseTUetaYSerinoR: Effects of leptin on fasting-induced inhibition of neuronal nitric oxide synthase mRNA in the paraventricular and supraoptic nuclei of rats. Brain Res1999; 846: 229–235.
31.
LópezMSeoaneLGarciaMD: Leptin regulation of prepro-orexin-A and orexin-A receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun2000; 269: 41–45.
32.
VgontzasANPapanicolaouDABixlerEO: Sleep apnea and daytime sleepiness and fatigue: Relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab2000; 85: 1151–1158.
33.
BronskyJNedvidkovaJZamrazilovaH: Dynamic changes of orexin-A and leptin in obese children during body weight reduction. Physiol Res2007; 56: 89–96.
34.
SugimotoTNagakeYSugimotoS: Plasma orexin concentrations in patients on hemodialysis. Nephron2002; 90: 379–383.
35.
CaiXJWiddowsonPSHarroldJ: Hypothalamic orexin expression: Modulation by blood glucose and feeding. Diabetes1999; 48: 2132–2137.
36.
HiguchiSUsuiAMurasakiM: Plasma orexin-A is lower in patients with narcolepsy. Neurosci Lett2002; 318: 61–64.
37.
MatsumuraTNakayamaMSatohH: Plasma orexin-A levels and body composition in COPD. Chest2003; 123: 1060–1065.
